Urinary test
PreclinicalBiologic
Urinary test is one of 14 biologic programs targeting Systemic. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
13
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
14 competitors in Systemic
#DrugCompanyPhaseTrials
1Vivotif Typhoid Oral Vaccine
UUniversity of Maryland, Baltimore
Phase 3
Robitussin
PfizerPhase 1
Versed
CConrado Roberto Hoffmann Filho
Phase 1
Darzalex
Johnson & JohnsonPreclinical
Venclexta
AbbViePreclinical
Nipride
EExela Pharma Sciences, LLC.
Preclinical
Miochol
BBausch Health Americas, Inc.
Preclinical
Velcade
SShilpa Grover, MD, MPH
Preclinical
Decadron
AAspen Global Incorporated
Preclinical
PIT565
NovartisPhase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Urinary test. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- FFrench Cardiology Society